DMD and Duchenne muscular dystrophy: A corollarium to these findings, if they were to be translated to human dystrophin-deficient muscle, would be that DMD patients carrying the G genotype (those who lost ambulation earlier in the original report of SPP1 as a DMD modifier [27]) are expected to express less osteopontin.